XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities    
Net income (loss) $ 68,577,000 $ 35,415,000
Adjustments to reconcile net income to cash flow provided by operating activities:    
Loss (gain) on sale of hotel properties, net 28,000 (996,000)
Loss on extinguishment of indebtedness, net 169,000 0
Depreciation and amortization 134,648,000 140,346,000
Amortization of deferred financing costs 4,528,000 4,522,000
Other amortization 3,662,000 1,827,000
Reclassification of unrealized gains on discontinued cash flow hedges to other income, net 0 (5,866,000)
Equity in income from unconsolidated joint ventures (315,000) (255,000)
Amortization of share-based compensation 18,028,000 16,075,000
Changes in assets and liabilities:    
Hotel and other receivables, net (9,462,000) (11,428,000)
Prepaid expense and other assets 8,388,000 8,675,000
Accounts payable and other liabilities (1,175,000) 23,432,000
Advance deposits and deferred revenue 7,226,000 1,537,000
Accrued interest (8,114,000) (9,618,000)
Net cash flow provided by operating activities 226,188,000 203,666,000
Cash flows from investing activities    
Payments to Acquire Real Estate Held-for-investment 0 59,219,000
(Payments) proceeds from sales of hotel properties, net (28,000) 48,053,000
Improvements and additions to hotel properties (101,980,000) (86,638,000)
Net cash flow used in investing activities (102,008,000) (97,804,000)
Cash flows from financing activities    
Repayment of Revolver 0 (200,000,000)
Borrowings on Term Loans 320,000,000 0
Repayments of Term Loans (318,662,000) 0
Repurchase of common shares under a share repurchase program (66,783,000) (50,000,000)
Repurchase of common shares to satisfy employee tax withholding requirements (4,398,000) (3,598,000)
Distributions on preferred shares (18,836,000) (18,836,000)
Distributions on common shares (33,577,000) (5,152,000)
Distributions on Operating Partnership units (149,000) (18,000)
Payments of deferred financing costs (7,791,000) (17,000)
Contributions from consolidated joint venture partners 0 154,000
Distribution to consolidated joint venture partners 0 (2,614,000)
Net cash flow used in financing activities (130,196,000) (280,081,000)
Net change in cash, cash equivalents, and restricted cash reserves (6,016,000) (174,219,000)
Cash, cash equivalents, and restricted cash reserves, beginning of year 536,386,000 713,869,000
Cash, cash equivalents, and restricted cash reserves, end of period $ 530,370,000 $ 539,650,000